Literature DB >> 16600393

A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition.

Annabelle M Belcher1, Steven J O'Dell, John F Marshall.   

Abstract

A neurotoxic regimen of methamphetamine impairs object recognition (OR) in rats. The present study investigated whether neurotoxicity is a necessary component of methamphetamine's effect on OR. Animals were exposed to a sensitizing regimen of methamphetamine, and were tested for OR one week, and locomotor behavior two weeks, later. Quantitative autoradiography was used to measure [(125)I]RTI-55 binding to forebrain dopaminergic and serotonergic transporters. Methamphetamine treatment produced significant OR impairments (and increased locomotion), without reducing dopamine or serotonin transporter binding. This study supports the conclusion that factors other than monoamine terminal injury contribute to the methamphetamine-induced cognitive impairments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600393     DOI: 10.1016/j.bbr.2006.02.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  18 in total

1.  Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats.

Authors:  Marley D Kass; Xiangqian Liu; Michael Vigorito; Linda Chang; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-09       Impact factor: 4.147

2.  Automation of the novel object recognition task for use in adolescent rats.

Authors:  Janelle M Silvers; Steven B Harrod; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurosci Methods       Date:  2007-08-23       Impact factor: 2.390

3.  Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression.

Authors:  Carmela M Reichel; Meghin G Gilstrap; Lauren A Ramsey; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

4.  Methamphetamine-induced changes in the object recognition memory circuit.

Authors:  Carmela M Reichel; Lauren A Ramsey; Marek Schwendt; Jacqueline F McGinty; Ronald E See
Journal:  Neuropharmacology       Date:  2011-11-18       Impact factor: 5.250

5.  Work aversion and associated changes in dopamine and serotonin transporter after methamphetamine exposure in rats.

Authors:  Alisa R Kosheleff; Millie Grimes; Steve J O'Dell; John F Marshall; Alicia Izquierdo
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

Review 6.  Methamphetamine influences on brain and behavior: unsafe at any speed?

Authors:  John F Marshall; Steven J O'Dell
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

7.  Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit.

Authors:  Ashley North; Jarod Swant; Michael F Salvatore; Joyonna Gamble-George; Petra Prins; Brittany Butler; Mukul K Mittal; Rebecca Heltsley; John T Clark; Habibeh Khoshbouei
Journal:  Synapse       Date:  2013-02-08       Impact factor: 2.562

8.  Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice.

Authors:  Curtis E Grace; Tori L Schaefer; Nicole R Herring; Devon L Graham; Matthew R Skelton; Gary A Gudelsky; Michael T Williams; Charles V Vorhees
Journal:  Neurotoxicol Teratol       Date:  2010-01-21       Impact factor: 3.763

9.  Dissociation between long-lasting behavioral sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task.

Authors:  Jessica J Stanis; Hector Marquez Avila; Martin D White; Joshua M Gulley
Journal:  Psychopharmacology (Berl)       Date:  2008-05-13       Impact factor: 4.530

Review 10.  A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.

Authors:  Martin Sarter; Vicente Martinez; Rouba Kozak
Journal:  Psychopharmacology (Berl)       Date:  2008-07-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.